Producer
Gulbrandsen Chemicals
Specialty inorganics maker; aluminum chlorohydrate and antiperspirant actives.
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Gulbrandsen Chemicals supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Gulbrandsen Chemicals makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Personal Care Actives
55%Industrial & Water Treatment
28%Specialty Inorganics
17%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Gulbrandsen produces both the OTC antiperspirant active (aluminum zirconium tetrachlorohydrex glycine) that goes into the Old Spice stick on every drugstore shelf AND the pharmaceutical-grade aluminum chloride hexahydrate that dermatologists prescribe under brand names like Drysol and Xerac AC for severe hyperhidrosis — the medical condition involving uncontrollable excessive sweating. OTC antiperspirant actives (AZTG) reduce perspiration by approximately 20-30% through plugging eccrine gland pores; prescription aluminum chloride hexahydrate (20-25% solution in anhydrous ethanol) achieves 80-90%+ sweat reduction but requires prescription due to its irritation potential and systemic absorption concerns. Gulbrandsen's production capabilities span from the OTC self-care product to the FDA-regulated pharmaceutical — selling aluminum compounds at two ends of the same therapeutic indication (sweat reduction) under two different regulatory pathways (cosmetic/OTC drug vs. prescription drug), with the same underlying chemistry. A supply disruption at Gulbrandsen would affect both CVS's deodorant aisle and dermatologists' prescription pads simultaneously.
Gulbrandsen Technologies Inc. ↗Concentration2024
The US market for FDA OTC-qualified antiperspirant actives is effectively a duopoly between Summit Reheis and Gulbrandsen, with a small contribution from European suppliers (Giulini Chemie/BASF grades). Consumer product companies including Procter & Gamble, Unilever, Henkel, and Colgate-Palmolive require dual-qualified sources for critical raw materials, particularly OTC drug actives, to meet FDA supply continuity guidance. This means both Summit Reheis and Gulbrandsen are simultaneously on the approved supplier lists of every major US antiperspirant brand. The antiperspirant active supply chain's concentration in two North American facilities creates an unusual systemic risk: a geographic concentration event (industrial accident, natural disaster, regulatory action affecting the northeastern US where both companies operate) could simultaneously remove both qualified suppliers from the US market, forcing consumer product companies to either discontinue antiperspirant products or accept extended lead times while new suppliers are qualified under the FDA OTC drug monograph.
US Food and Drug Administration ↗Origin2024
Gulbrandsen Chemicals evolved from a specialty inorganic chemistry manufacturer focused on precision aluminum salt synthesis. While Summit Reheis became the "brand name" in aluminum antiperspirant actives through its Reheis heritage (the inventor of ACH for deodorant), Gulbrandsen built its position as the second-qualified source for the same FDA OTC-regulated compounds — a strategically important role for consumer product companies that require supply redundancy. Gulbrandsen's differentiation is in the breadth of aluminum complex grades: they supply the full range from aluminum chlorohydrate (aerosol deodorant) to aluminum zirconium tetrachlorohydrex glycine (stick antiperspirant) to aluminum chloride hexahydrate USP (prescription hyperhidrosis treatment). This spectrum allows Gulbrandsen to serve the same personal care industry from the OTC mass-market channel through the Rx pharmaceutical channel, using related but distinctly different purity and regulatory qualification pathways.
Gulbrandsen Technologies Inc. ↗